A company residing in the Sirius Innovation and Technology Center (INTC) plans to conduct experiments on primate cloning to create new drugs and treatments. In particular, scientists intend to focus on improving the efficiency of reproductive technologies for humans.
Scientists plan to use them to study the development of embryos and genetic diseases. The data obtained will be used to develop new drugs and test treatments.
According to Alexander Kuznetsov, CEO of Artklontek, researchers intend to develop methods in experiments involving monkeys that will help increase the effectiveness of reproductive technologies for humans.
Today, one of the most important tasks is to increase the reproductive capacity of human embryos for the IVF procedure. Currently, the effectiveness of embryo transfer varies from 40 to 60%, and in some cases the process becomes extremely complex, forcing repeated expensive procedures.
Earlier, a virtual human cell was created in Sirius, which will allow scientists to test their hypotheses without the use of living organisms.
Read more on the topic:
Scientists from NSU have created a powerful AI that works on the principle of the human brain
A new era of machine learning: Saratov scientists have found an alternative to neural networks
